Background Primary squamous cell carcinoma (SCC) of the salivary gland is a rare disease, and distinguishing primary SCC from metastatic SCC is difficult. This study investigated the histological and immunohistochemical differences between primary and metastatic salivary gland SCC to improve the accuracy of diagnosis and to explore the pathogenesis of this disease.
Methods Data of 16 patients who underwent surgery for SCC of salivary glands between 2000 and 2018 at Asan Medical Center were retrieved. Eight patients had a history of SCC at other sites, and eight patients had only salivary gland SCC. Immunostaining for p16, p53, androgen receptor (AR), gross cystic disease fluid protein 15 (GCDFP-15), and c-erbB2, as well as mucicarmine staining, were compared between the two groups.
Results Most tumors were located in the center of the salivary glands with extraparenchymal extension. The histology of primary SCC of the salivary gland was consistent with moderately differentiated SCC with extensive desmoplastic reaction and peritumoral inflammation. Involvement of the salivary gland ducts and transition into the ductal epithelium were observed in two cases. Metastatic SCC resembled the primary tumor histologically and was associated with central necrosis. Both groups exhibited negative mucin staining. Two, one, and one primary SCC case exhibited AR, GCDFP-15, and c-erbB2 positivity, respectively.
Conclusions A subset of primary SCCs originated in salivary ducts or was related to salivary duct carcinoma. Distinguishing primary from metastatic SCC of the salivary gland is difficult using histologic features and immunoprofiles. A comprehensive review of the medical history is essential.
Citations
Citations to this article as recorded by
Primary salivary gland squamous cell carcinoma with sialolithiasis in the submandibular gland: A case report and literature review Sawako Ono, Katsutoshi Hirose, Yuji Hirata, Marie Yamada, Satoko Nakamura, Hidetaka Yamamoto Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2024; 36(5): 768. CrossRef
A case of primary squamous cell carcinoma of the parotid gland and review of the literature Jingli Zhao, Xinrong Nan, Chuhuan Zhou, Nan Jiang, Liangliang Tian Journal of Case Reports and Images in Oncology.2024; 10(1): 7. CrossRef
Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland Patrick J. Bradley, Göran Stenman, Lester D. R. Thompson, Alena Skálová, Roderick H. W. Simpson, Pieter J. Slootweg, Alessandro Franchi, Nina Zidar, Alfons Nadal, Henrik Hellquist, Michelle D. Williams, Ilmo Leivo, Abbas Agaimy, Alfio Ferlito Virchows Archiv.2024; 485(1): 3. CrossRef
Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature Lindsay Holic Medical Oncology.2024;[Epub] CrossRef
Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases Melad N Dababneh, Christopher C Griffith, Kelly R Magliocca, Ivan J Stojanov Histopathology.2024; 85(4): 590. CrossRef
Comprehensive Next Generation Sequencing Reveals that Purported Primary Squamous Cell Carcinomas of the Parotid Gland are Genetically Heterogeneous Justin A. Bishop, Masato Nakaguro, Ilan Weinreb, Doreen Palsgrove, Lisa M. Rooper, Travis W. Vandergriff, Brian Carlile, Jeffrey A. Sorelle, Jeffrey Gagan, Toshitaka Nagao Head and Neck Pathology.2024;[Epub] CrossRef
Salivary gland fine needle aspiration: a focus on diagnostic challenges and tips for achieving an accurate diagnosis Carla Saoud, Hansen Lam, Sandra I. Sanchez, Zahra Maleki Diagnostic Histopathology.2023; 29(8): 357. CrossRef
Salivary gland pathologies: evolution in classification and association with unique genetic alterations Michał Żurek, Łukasz Fus, Kazimierz Niemczyk, Anna Rzepakowska European Archives of Oto-Rhino-Laryngology.2023; 280(11): 4739. CrossRef
A retrospective study of nonneoplastic and neoplastic disorders of the salivary glands Sorin Vamesu, Oana Andreea Ursica, Ana Maria Gurita, Raluca Ioana Voda, Mariana Deacu, Mariana Aschie, Madalina Bosoteanu, Georgeta Camelia Cozaru, Anca Florentina Mitroi, Cristian Ionut Orasanu Medicine.2023; 102(42): e35751. CrossRef
Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case Raed Farhat, Noam Asna, Yaniv Avraham, Ashraf Khater, Majd Asakla, Alaa Safia, Sergio Szvalb, Nidal Elkhatib, Shlomo Merchavy Discover Oncology.2022;[Epub] CrossRef
Morphologic CT and MRI features of primary parotid squamous cell carcinoma and its predictive factors for differential diagnosis with mucoepidermoid carcinoma Xiaohua Ban, Huijun Hu, Yue Li, Lingjie Yang, Yu Wang, Rong Zhang, Chuanmiao Xie, Cuiping Zhou, Xiaohui Duan Insights into Imaging.2022;[Epub] CrossRef
A Rare Case of Primary Squamous Cell Carcinoma of the Submandibular Salivary Gland: Brief Overview of Diagnostic Ambiguity and Treatment Challenges Pawan Hingnikar, Anendd Jadhav, Nitin D Bhola Cureus.2022;[Epub] CrossRef
Necrotizing Sialometaplasia of the Hard Palate: Diagnosis and
Treatment Sangeun Lee, Yun Sung Lim, Kyuho Lee, Bo Hae Kim Journal of Clinical Otolaryngology Head and Neck
Surgery.2022; 33(4): 236. CrossRef
Parotid Salivary Duct Carcinoma With a Prominent Squamous Component: Immunohistochemical Profile, Diagnostic Pitfalls, and Therapeutic Implications Naomi Hardy, Joshua Thompson, Ranee Mehra, Cinthia B. Drachenberg, Kyle Hatten, John C. Papadimitriou International Journal of Surgical Pathology.2021; 29(7): 726. CrossRef
Intrasalivary Thymic Carcinoma: A Case Report and Literature Review Michał Kunc, Alexandra Kamieniecki, Grzegorz Walczak, Tomasz Nowicki, Bartosz Wasąg, Bogusław Mikaszewski, Dominik Stodulski, Wojciech Biernat Head and Neck Pathology.2021; 16(3): 857. CrossRef
Cancer Stem Cell Markers in Squamous Cell Carcinomas of the Salivary Glands Mattis Bertlich, Julia Kitz, Marie Kruizenga, Jennifer Lee Spiegel, Martin Canis, Friedrich Ihler, Frank Haubner, Bernhard G. Weiss, Mark Jakob Oncology.2021; 99(6): 402. CrossRef